We identified that CAR, CD46 and DSG2 expression in GBM and patient-derived GBM cells and GBM stem cells can be transduced by HAdV-C5-based adenoviral serotypes, in particular HAdV-C5/D49K. The gene discussed is CD46; the disease is glioblastoma.